AURKA and hepatocellular carcinoma: AURKA's potential role in modulating immune checkpoints and influencing immune cell infiltration within the HCC microenvironment suggests that combining AURKA inhibitors with immune checkpoint inhibitors could be an effective therapeutic approach for patients.